SURG

SurgePays, Inc. [SURG] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SURG Stock Summary

Top SURG Correlated Resources

SURG


Top 10 Correlated ETFs

SURG


Top 10 Correlated Stocks

SURG


In the News

06:34 10 Jun 2023 SURG

7 Stocks With 1,000% Upside Potential

While market advocates will wince at accusations that investing is nothing more than legalized gambling, for these stocks with massive upside potential, I for one will have to concede that only speculators should read ahead. Though these enterprises may have yield lifechanging returns, they can quickly leave you in the poor house.

09:39 10 Jun 2023 SURG

1606 Corp inks product distribution deal with SurgePays

1606 Corp announced that it has completed a distribution deal with Nasdaq-listed SurgePays, Inc, in which SurgePays has agreed to distribute 1606 Corp's Hemp smokable products to its thousands of registered retail store customers. The acquisition-based CBD company said SurgePays has already taken possession of 1,000 six-pack displays and is currently distributing them to registered retail store customers, along with 1606's CBD Singlz brand.

11:30 10 Jun 2023 SURG

SurgePays, Inc. (SURG) Q4 2022 Earnings Call Transcript

SurgePays, Inc. (NASDAQ:SURG ) Q4 2022 Earnings Conference Call March 30, 2023 5:00 PM ET Company Participants Brian Prenoveau - Investor Relations Brian Cox - President and Chief Executive Officer Tony Evers - Chief Financial Officer Conference Call Participants Michael Diana - Maxim Group Ed Woo - Ascendiant Capital Operator Greetings and welcome to the SurgePays Inc. Fourth Quarter and 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

08:30 10 Jun 2023 SURG

SurgePays Announces 2022 Preliminary Financial Results and Schedules Fourth Quarter and Full Year 2022 Earnings Call

Q4 Positive Cash Flow over $2 million with sales over $35 million Q4 Positive Cash Flow over $2 million with sales over $35 million

12:27 10 Jun 2023 SURG

A Virtuous Cycle At SurgePays

The company has removed bottlenecks from its already triple-rate subscriber growth of its mobile broadband business, setting it up for a significant acceleration. It will also use that business to expand its network of partner community shops as this is easy money for prospective shops.

01:25 10 Jun 2023 SURG

Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks?

On Tuesday, Aveo shares soared 42% in massive volume on news that it will get acquired by South Korea's LG Chem. The post Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks?

03:21 10 Jun 2023 SURG

3 Stock Bets For 2023

Here are three stocks that, for various reasons, could produce outside returns in 2023. While neither of these is risk-free, we think that the upside potential of each is well worth taking a position (which we have in all three for our marketplace).

12:49 10 Jun 2023 SURG

PXMD, GETY: The Top 5 Short Squeeze Stocks to Watch This Week

We're checking in on the top short squeeze stocks to watch this week as traders continue to have an interest in this part of the market! Short squeeze stocks are often subject to volatility with massive gains.

02:23 10 Jun 2023 SURG

SurgePays Keeps Growing

Revenues up 149%, following subscriber growth but the bottom line isn't yet improving as a result of upfront costs (the tablets, sales commissions, etc.) keep increasing. New financing based on government receivables is as good as done, should remove a bottleneck as they can pre-finance more tablets.

09:49 10 Jun 2023 SURG

SurgePays, Inc. (SURG) Q3 2022 Earnings Call Transcript

SurgePays, Inc. (NASDAQ:SURG ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Brian Prenoveau – Investor Relations Brian Cox – President and Chief Executive Officer Tony Evers – Chief Financial Officer Conference Call Participants Michael Diana – Maxim Group Ed Woo – Ascendiant Capital Jeff Kone – The Wall Street Resource Operator Good day, and welcome to the SurgePays Incorporated Third Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode.

SURG Financial details

Company Rating
Strong Buy
Market Cap
106.78M
Income
5.6M
Revenue
135.18M
Book val./share
0.7
Cash/share
0.63
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
09 Aug 2023
P/E
20.56
Forward P/E
-
PEG
-1.89
P/S
0.85
P/B
11.69
P/C
12.56
P/FCF
17.93
Quick Ratio
0.72
Current Ratio
1.33
Debt / Equity
3.1
LT Debt / Equity
0.5
-
-
EPS (TTM)
0.23
EPS next Y
-
EPS next Q
-
EPS this Y
-99.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-58.2%
Revenue last 5Y
51.47%
Revenue Q/Q
-4%
EPS Q/Q
363.77%
-
-
-
-
SMA20
62.41%
SMA50
68.67%
SMA100
9.38%
Inst Own
17.76%
Inst Trans
0.02%
ROA
14%
ROE
127%
ROC
0.43%
Gross Margin
14%
Oper. Margin
5%
Profit Margin
4%
Payout
-
Shs Outstand
14.16M
Shs Float
8.3M
-
-
-
-
Target Price
-
52W Range
3.88-7.715
52W High
+13%
52W Low
+163.67%
RSI
75.49
Rel Volume
1.73
Avg Volume
150.7K
Volume
260.27K
Perf Week
12.52%
Perf Month
68.66%
Perf Quarter
9.1%
Perf Half Y
12.36%
-
-
-
-
Beta
1.4993
-
-
Volatility
0.52%, 1.22%
Prev Close
4.91%
Price
7.91
Change
8.5%

SURG Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
9.3413.3825.4911.659.81
Net income per share
-0.94-4.9-5.84-2.58-0.01
Operating cash flow per share
-0.62-3.4-2.03-3.490.06
Free cash flow per share
-0.62-3.51-2.03-3.50.01
Cash per share
0.270.180.321.430.57
Book value per share
-1.22-2.44-5.030.810.4
Tangible book value per share
-1.79-5.37-7.36-0.170.02
Share holders equity per share
-1.22-2.44-5.030.810.4
Interest debt per share
0.864.545.183.470.81
Market cap
31M28.86M12.59M8.85M81.31M
Enterprise value
31.81M37.01M19.59M10.25M82.39M
P/E ratio
-20.11-3.06-1.01-0.78-546.27
Price to sales ratio
2.031.120.230.170.67
POCF ratio
-30.52-4.42-2.91-0.58102.5
PFCF ratio
-30.52-4.27-2.91-0.58858.73
P/B Ratio
-15.59-6.14-1.172.4916.29
PTB ratio
-15.59-6.14-1.172.4916.29
EV to sales
2.091.440.360.20.68
Enterprise value over EBITDA
-23.69-5.32-4.63-1.444.24
EV to operating cash flow
-31.32-5.67-4.53-0.67103.86
EV to free cash flow
-31.32-5.47-4.52-0.67870.09
Earnings yield
-0.05-0.33-0.99-1.280
Free cash flow yield
-0.03-0.23-0.34-1.730
Debt to equity
-3.05-3.12-1.684.495.79
Debt to assets
1.491.472.460.820.85
Net debt to EBITDA
-0.61-1.17-1.65-0.190.58
Current ratio
0.640.510.081.391.17
Interest coverage
-10.93-29.88-2.48-0.80.45
Income quality
0.660.770.41.13-1.43
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.420.170.210.1
Research and developement to revenue
00000
Intangibles to total assets
0.230.560.680.220.14
Capex to operating cash flow
00.0300-0.88
Capex to revenue
0-0.0100-0.01
Capex to depreciation
0-0.80-0.06-0.71
Stock based compensation to revenue
0.010.01000
Graham number
5.0916.4125.696.860.33
ROIC
27.47-1.637.14-0.720.02
Return on tangible assets
-0.49-2.17-5.34-0.74-0.01
Graham Net
-2.88-6.23-7.96-1.15-0.75
Working capital
-1.73M-3.48M-14.05M3.89M4.1M
Tangible asset value
-2.92M-10.34M-15.72M-748.95K284.31K
Net current asset value
-3.01M-11.11M-16.8M-2.06M-1.32M
Invested capital
-0.63-1.81-0.712.161.63
Average receivables
651.84K2.19M1.76M1.82M6.24M
Average payables
1.87M3.95M5.99M3.67M3.76M
Average inventory
0089.15K2.27M7.77M
Days sales outstanding
29.8744.412.6423.2327.72
Days payables outstanding
138.5983.3451.61025.37
Days of inventory on hand
001.2535.4437.78
Receivables turnover
12.228.22138.415.7113.17
Payables turnover
2.634.387.07014.38
Inventory turnover
00291.2810.39.66
ROE
0.782.011.16-3.18-0.03
Capex per share
0-0.120-0.01-0.06

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
Revenue per share
1.752.282.912.922.46
Net income per share
-0.1-0.04-0.120.250.32
Operating cash flow per share
-0.280.01-0.060.380.2
Free cash flow per share
-0.28-0.01-0.040.350.19
Cash per share
0.290.710.630.570.63
Book value per share
0.20.170.050.40.7
Tangible book value per share
-0.15-0.21-0.330.020.37
Share holders equity per share
0.20.170.050.40.7
Interest debt per share
0.691.171.160.690.52
Market cap
49.22M59.26M56.62M81.31M63.45M
Enterprise value
53.89M64.29M62.49M82.39M61.81M
P/E ratio
-10.15-33-9.196.683.49
Price to sales ratio
2.332.121.572.241.82
POCF ratio
-14.81337.68-70.5117.1422.14
PFCF ratio
-14.76-475.9-112.9718.6723.42
P/B Ratio
20.6227.989.6116.296.44
PTB ratio
20.6227.989.6116.296.44
EV to sales
2.552.31.732.271.78
Enterprise value over EBITDA
-61.22-105.37-83.0520.0712.32
EV to operating cash flow
-16.21366.34-77.8317.3721.57
EV to free cash flow
-16.16-516.29-124.718.9222.82
Earnings yield
-0.02-0.01-0.030.040.07
Free cash flow yield
-0.070-0.010.050.04
Debt to equity
6.4712.8652.075.793.1
Debt to assets
0.870.930.990.850.75
Net debt to EBITDA
-5.31-8.24-7.810.26-0.33
Current ratio
1.391.0711.171.33
Interest coverage
-6.19-1.4-1.467.1824.46
Income quality
2.67-0.20.461.420.63
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.160.10.080.080.08
Research and developement to revenue
00000
Intangibles to total assets
0.230.160.140.140.12
Capex to operating cash flow
0-1.71-0.38-0.08-0.05
Capex to revenue
0-0.010.01-0.010
Capex to depreciation
-0.06-1.490.97-1.39-0.57
Stock based compensation to revenue
00000.01
Graham number
0.670.380.381.492.25
ROIC
-0.260.31-2.560.260.29
Return on tangible assets
-0.09-0.02-0.050.10.13
Graham Net
-0.52-0.78-1.06-0.75-0.48
Working capital
3.49M1.42M53.23K4.1M8.57M
Tangible asset value
-1.78M-2.6M-4.15M284.31K5.19M
Net current asset value
-3.04M-4.57M-5.91M-1.32M3.63M
Invested capital
3.46.4721.81.630.73
Average receivables
4.45M6.98M8.9M9.35M9.44M
Average payables
3.51M10.25M15.35M12.37M7.56M
Average inventory
3.72M4.38M7.58M10.34M13.35M
Days sales outstanding
24.0326.7523.5622.9325
Days payables outstanding
34.1146.9945.2722.9225.29
Days of inventory on hand
14.9619.7924.9434.1251.58
Receivables turnover
3.753.363.823.923.6
Payables turnover
2.641.921.993.933.56
Inventory turnover
6.024.553.612.641.74
ROE
-0.51-0.21-2.440.610.46
Capex per share
0-0.020.02-0.03-0.01

SURG Frequently Asked Questions

What is SurgePays, Inc. stock symbol ?

SurgePays, Inc. is a US stock , located in Bartlett of Tn and trading under the symbol SURG

What is SurgePays, Inc. stock quote today ?

SurgePays, Inc. stock price is $7.91 today.

Is SurgePays, Inc. stock public?

Yes, SurgePays, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap